<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; Voices from the Fight to Stop Tuberculosis</title>
	<atom:link href="http://blog.newtbdrugs.org/category/tb-voices/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.newtbdrugs.org</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Fri, 03 Sep 2010 14:16:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Interview with Dr. Lee Reichman &#8211; Part Three</title>
		<link>http://blog.newtbdrugs.org/2010/09/interview-with-dr-lee-reichman-part-three/</link>
		<comments>http://blog.newtbdrugs.org/2010/09/interview-with-dr-lee-reichman-part-three/#comments</comments>
		<pubDate>Fri, 03 Sep 2010 14:15:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[usa]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=1538</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/09/interview-with-dr-lee-reichman-part-three/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/07/lee-reichman-150x150.png" class="imgtfe" hspace="5" width="100"  border=0></a>This is part three of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine, Preventive Medicine and Community Health at the New Jersey Medical School, in Newark, New Jersey.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/09/interview-with-dr-lee-reichman-part-three/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview with Dr. Lee Reichman – Part Two</title>
		<link>http://blog.newtbdrugs.org/2010/08/interview-with-dr-lee-reichman-%e2%80%93-part-two/</link>
		<comments>http://blog.newtbdrugs.org/2010/08/interview-with-dr-lee-reichman-%e2%80%93-part-two/#comments</comments>
		<pubDate>Thu, 26 Aug 2010 17:01:50 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[usa]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=1531</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/08/interview-with-dr-lee-reichman-%e2%80%93-part-two/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/07/lee-reichman-150x150.png" class="imgtfe" hspace="5" width="100"  border=0></a>This is part two of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the  New Jersey Medical School Global Tuberculosis Institute, and Professor  of Medicine, Preventive Medicine and Community Health at the New Jersey  Medical School, in Newark, New Jersey.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/08/interview-with-dr-lee-reichman-%e2%80%93-part-two/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Viewpoint: We Need New TB Drugs &#8211; Part Two</title>
		<link>http://blog.newtbdrugs.org/2010/08/viewpoint-we-need-new-tb-drugs-part-two/</link>
		<comments>http://blog.newtbdrugs.org/2010/08/viewpoint-we-need-new-tb-drugs-part-two/#comments</comments>
		<pubDate>Thu, 19 Aug 2010 13:00:46 +0000</pubDate>
		<dc:creator>Cameron Kaiser</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=1445</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/08/viewpoint-we-need-new-tb-drugs-part-two/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/08/Cameron-Kaiser-21.jpg" class="imgtfe" hspace="5" width="100"  border=0></a>Last week, Dr. Kaiser shared his thoughts and perspectives as a medical doctor on the current state of TB drug regimens.  This week he shares specific ideas on how TB drug R&#38;D could be improved. ]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/08/viewpoint-we-need-new-tb-drugs-part-two/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Viewpoint: We Need New TB Drugs &#8211; Part One</title>
		<link>http://blog.newtbdrugs.org/2010/08/viewpoint-we-need-new-tb-drugs-part-one/</link>
		<comments>http://blog.newtbdrugs.org/2010/08/viewpoint-we-need-new-tb-drugs-part-one/#comments</comments>
		<pubDate>Thu, 12 Aug 2010 20:46:00 +0000</pubDate>
		<dc:creator>Cameron Kaiser</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=1431</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/08/viewpoint-we-need-new-tb-drugs-part-one/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/08/Cameron-Kaiser-2.jpg" class="imgtfe" hspace="5" width="100"  border=0></a>Antibiotics are, to the typical patient, always the quick fix. Despite our best attempts to convince them that their viral bronchitis will get better without that course of amoxicillin, anyone who has worked a primary care clinic knows the pressure to throw antibiotics at the problem, even when we ourselves know it's not the answer, because our patients perceive it as the fast track to health. A couple weeks, they reason, and the infection is over.  Normalcy ought to resume. Then you tell them they have tuberculosis, and "normalcy" is at least six months away, if everything goes according to plan. And tuberculosis is a wily enough contender to make sure everything won't.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/08/viewpoint-we-need-new-tb-drugs-part-one/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Interview with Dr. Lee Reichman &#8211; Part One</title>
		<link>http://blog.newtbdrugs.org/2010/07/interview-with-dr-lee-reichman/</link>
		<comments>http://blog.newtbdrugs.org/2010/07/interview-with-dr-lee-reichman/#comments</comments>
		<pubDate>Fri, 30 Jul 2010 19:16:25 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=1340</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/07/interview-with-dr-lee-reichman/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/07/lee-reichman-150x150.png" class="imgtfe" hspace="5" width="100"  border=0></a>This is part one of our interview with Lee B. Reichman, MD, MPH, Founding Executive Director of the  New Jersey Medical School Global Tuberculosis Institute, and Professor  of Medicine, Preventive Medicine and Community Health at the New Jersey  Medical School, in Newark, New Jersey.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/07/interview-with-dr-lee-reichman/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Stop TB Partnership Craig David Video Series #3</title>
		<link>http://blog.newtbdrugs.org/2010/06/stop-tb-partnership-craig-david-video-series-3/</link>
		<comments>http://blog.newtbdrugs.org/2010/06/stop-tb-partnership-craig-david-video-series-3/#comments</comments>
		<pubDate>Thu, 24 Jun 2010 14:00:11 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[stop tb]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=1124</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/06/stop-tb-partnership-craig-david-video-series-3/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/06/Dr-Sizulu-Moyo-150x150.png" class="imgtfe" hspace="5" width="100"  border=0></a>In a newly released clip – the third in a series of videos shot in South Africa during his first country visit as a Goodwill Ambassador against Tuberculosis – British R&#038;B star Craig David talks with Dr Sizulu Moyo, a tuberculosis researcher at Stellenbosch University.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/06/stop-tb-partnership-craig-david-video-series-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stop TB Partnership Craig David Video Series #2</title>
		<link>http://blog.newtbdrugs.org/2010/06/stop-tb-partnership-craig-david-video-series-2/</link>
		<comments>http://blog.newtbdrugs.org/2010/06/stop-tb-partnership-craig-david-video-series-2/#comments</comments>
		<pubDate>Thu, 10 Jun 2010 14:09:52 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=1029</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/06/stop-tb-partnership-craig-david-video-series-2/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/06/craig-david-2-150x150.png" class="imgtfe" hspace="5" width="100"  border=0></a>The Stop TB Partnership has produced a series of videos featuring Goodwill Ambassador Craig David. This is #2 in a series.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/06/stop-tb-partnership-craig-david-video-series-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Interview with Martino Laurenzi, M.D., MPH</title>
		<link>http://blog.newtbdrugs.org/2010/06/an-interview-with-martino-laurenzi-m-d-mph/</link>
		<comments>http://blog.newtbdrugs.org/2010/06/an-interview-with-martino-laurenzi-m-d-mph/#comments</comments>
		<pubDate>Thu, 03 Jun 2010 13:00:32 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=1002</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/06/an-interview-with-martino-laurenzi-m-d-mph/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/06/martino-laurenzi-150x150.png" class="imgtfe" hspace="5" width="100"  border=0></a>Dr. Martino Laurenzi, an expert in clinical development and community health, is a Clinical Research Scientist at the TB Alliance, where his responsibilities include the oversight of clinical trials. Dr. Laurenzi has long been involved in public health research; the Gubbio Study, which he started in 1982 in the Italian town for which it is named, is one of the longest standing population-based epidemiological studies for the screening of cardiovascular risk factors.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/06/an-interview-with-martino-laurenzi-m-d-mph/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An Interview with Michael D. Iseman, M.D.</title>
		<link>http://blog.newtbdrugs.org/2010/05/an-interview-with-michael-d-iseman-m-d/</link>
		<comments>http://blog.newtbdrugs.org/2010/05/an-interview-with-michael-d-iseman-m-d/#comments</comments>
		<pubDate>Thu, 27 May 2010 13:00:16 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=975</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/05/an-interview-with-michael-d-iseman-m-d/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/05/iseman.jpg" class="imgtfe" hspace="5" width="100"  border=0></a>Dr. Michael D. Iseman is a Professor of Medicine in the Divisions of Pulmonary  Medicine and Infectious Diseases at the University of Colorado School of Medicine. This video was recorded on November 13, 2009 at Johns Hopkins University.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/05/an-interview-with-michael-d-iseman-m-d/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dr. Michele Miller on TB in Wildlife &#8211; Part Three of Three</title>
		<link>http://blog.newtbdrugs.org/2010/05/dr-michele-miller-on-tb-in-wildlife-part-three-of-three/</link>
		<comments>http://blog.newtbdrugs.org/2010/05/dr-michele-miller-on-tb-in-wildlife-part-three-of-three/#comments</comments>
		<pubDate>Tue, 25 May 2010 13:00:26 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB R&D Spotlight Interviews]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[voices]]></category>
		<category><![CDATA[wildlife]]></category>

		<guid isPermaLink="false">http://blog.newtbdrugs.org/?p=846</guid>
		<description><![CDATA[<a href=http://blog.newtbdrugs.org/2010/05/dr-michele-miller-on-tb-in-wildlife-part-three-of-three/><img src="http://blog.newtbdrugs.org/wp-content/uploads/2010/05/deer-250x192.png" class="imgtfe" hspace="5" width="100"  border=0></a>TB R&#038;D Spotlight Interview with Dr. Michele Miller: In part three of our talk with Dr. Michele Miller, the Chief Veterinary Officer and Director of the Center for Conservation Medicine at the Palm Beach Zoo, an expert on tuberculosis in wildlife populations, we discuss the state of funding to stop TB in wild animals.]]></description>
		<wfw:commentRss>http://blog.newtbdrugs.org/2010/05/dr-michele-miller-on-tb-in-wildlife-part-three-of-three/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
